would be nice to see a little more push from management, page-23

Gas,

There's a YouTube of Chris somewhere, don't have the link, talking about how they went about the initial raise. Instead of just trying to raise a couple of million to keep the company afloat and see how it went, they approached the funds with the proposition that they needed $10 million to fund a clinically rigorous PH2b that would have the best chance of achieving the desired result. Being to prove the science. If they couldn't get the money, they would fold the company then and there. End of story.

The science has never been in doubt. The funds went away, did their DD, came back and gave them the money.​

Management is one of three key things you look for in an investment. I'd suggest CB, with his proven track record, was one of the reasons they stumped up the cash. He hasn't yet failed in any endeavour he has taken on.

I don't see FTT being his first.​

Each to their own, but if it's a bet on him being right, I'm in.

Not for pips, either.